Amber Mottola, FNP

Background

Where I come from

Fifteen years in emergency medicine teaches you to think quickly. It also shows you, over and over, what happens when metabolic disease goes unmanaged for a decade. I spent most of my career treating the downstream end of that — and rarely got to be part of the work that prevents it.

That is a large part of why I moved into clinical research. For more than six years I worked on studies involving GLP-1 medications, metabolic health, and emerging therapies, alongside patients using both approved and investigational treatments. It gave me something most prescribers do not have: a view of these medications from inside the trials that produced the data everyone now cites.

The practice

Why I started The Shape Theory

Weight loss medication has become easy to obtain and difficult to do well. Plenty of places will ship you a vial. Fewer will review your labs, ask what you have already tried, adjust when something is not working, and stay with you through maintenance — which is where most of the real work happens.

I built The Shape Theory for the second kind of care. Every plan starts with your history, your goals, and your lab work, rather than a protocol that was applied to a thousand people before you.

My approach

How I practice

What to expect

My goal is straightforward: that you feel confident in your care, informed about your options, and supported at every stage — not just while the number on the scale is moving.